Therapeutic Editing of the <i>TP53</i> Gene: Is CRISPR/Cas9 an Option?

by Regina Mirgayazova, Raniya Khadiullina, Vitaly Chasov, Rimma Mingaleeva, Regina Miftakhova, Albert Rizvanov, Emil Bulatov
Published 2020-06-01

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies

by Vitaly Chasov, Mikhail Zaripov, Regina Mirgayazova, Raniya Khadiullina, Ekaterina Zmievskaya, Irina Ganeeva, Aigul Valiullina, Albert Rizvanov, Emil Bulatov, Emil Bulatov
Published 2021-08-01

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy

by Vitaly Chasov, Regina Mirgayazova, Ekaterina Zmievskaya, Raniya Khadiullina, Aygul Valiullina, Joseph Stephenson Clarke, Albert Rizvanov, Matthias G. J. Baud, Emil Bulatov, Emil Bulatov
Published 2020-08-01